TrialCurrent Alzheimer research2017

Long-Term Extensions of Randomized Vaccination Trials of ACC-001 and QS-21 in Mild to Moderate Alzheimer's Disease.

Michael Hull et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.